Last updated on August 2019

Efficacy and Safety of MT-5199 in Subjects With Tardive Dyskinesia


Brief description of study

The purpose of this study is to evaluate the efficacy and safety of MT-5199 administered once daily for the treatment of Tardive Dyskinesia (TD) symptoms.

Clinical Study Identifier: NCT03176771

Recruitment Status: Closed


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.